Run continuous specialty physician research within one subscription
Verified HCP panel. AI-moderated voice and video interviews. HIPAA-compliant by default. BAA on every engagement. Monthly subscription with 50 interviews included — always-on listening across pharma's research backlog without sacrificing rigor.
Trusted by teams at
Pharma research teams face three constraints generic AI tools don't solve: specialty physician recruiting takes 8-12 weeks; every vendor must clear multi-arm legal review with BAA and Sunshine Act handling; and validation demands per launch outrun incumbent cycles. Carevoices delivers AI-moderated voice/video interviews with verified specialists across oncology, cardiology, neurology, GI, and rare disease — recruited in 7-21 days, HIPAA Safe Harbor de-identified, BAA included, stimuli pre-approval built in. Monthly subscription replaces RFP cycles. Buying-process, message validation, concept testing, advisory, tracker waves, and KOL deep-dives all run within it.
Why Pharma Research Teams Hate Custom Studies
Three structural constraints that generic research tools and panel rentals don't solve.
Specialty recruiting is the bottleneck on every custom study
Finding 25 GI oncology specialists, 50 cardiologists, or 30 hematology-oncologists is the bottleneck. Trackers help; ad-hoc research is brutal. Most vendors quote 6-10 weeks for fielding alone, before analysis even begins. By the time the deck lands, the brand decision window has closed.
Every vendor must clear multi-arm legal review
MR legal, brand legal, and pharmacovigilance teams each review every engagement. BAA required. Stimuli pre-approval. Identifier stripping. Sunshine Act documentation. Generic AI research tools fail every check; legacy vendors bolt the compliance package on as a separate workstream that delays fielding 30-60 days per study.
Validation demands rise per launch — incumbent cycles don't match
Brand teams expected to deliver more concept testing, more message validation, more advisory research per launch. Incumbent vendor velocity (8-12 weeks per study) compresses iteration into one-shot validation. No room for round 2 if the first signal is ambiguous, no room for ad-hoc deep-dives between scheduled tracker waves.
Medical Affairs and KOL programs run on incompatible vendor stacks
Medical Affairs runs KOL advisory boards and launch-readiness research on bespoke fielding partners; brand teams run concept testing on different vendors; tracker programs run on a third. Each stack has its own BAA, Sunshine Act handling, and stimuli pre-approval workflow — every cross-team engagement restarts compliance from scratch and stretches launch-readiness timelines past go-live windows.
How Does Carevoices Compress Pharma Research?
Pharma teams use Carevoices to run AI-moderated voice and video interviews with verified specialty HCPs, recruited in 7-21 days, delivered as HIPAA Safe Harbor de-identified transcripts under BAA. A monthly subscription with 50 interviews included replaces bespoke per-project RFP cycles — buying-process, message validation, concept testing, advisory, tracker waves, and KOL deep-dives all run within the same engagement. The compliance posture is built into the platform, not bolted on.
How does Carevoices recruit specialty physicians faster than incumbents?
Verified panel of HCPs with NPI auto-validated against the public NPPES Registry, license cross-checked against state board databases, and behavioral fingerprint built across interviews. Specialty recruiting runs 7-21 days vs. 4-8 weeks for typical pharma vendors. Direct NPI outreach available for rare specialties not pre-recruited.
What makes Carevoices' compliance posture defensible to pharma legal?
BAA on every healthcare engagement (template available before signature). PHI-safe transcript pipeline with no model training, no logging on customer data. HIPAA Safe Harbor de-identification applied to every transcript before delivery. Sunshine Act / Open Payments-ready data handling with NPI capture at intake. Stimuli pre-approval workflow with versioning and audit trail.
What's structurally different about Carevoices' delivery vs. legacy pharma research vendors?
AI-native delivery, a monthly subscription with 50 interviews included replacing bespoke per-project RFP cycles, compliance-as-architecture rather than retrofit, and always-on listening capability. Fielding starts the same week the brief is locked. We don't replace panel rentals — we provide AI moderation, compliance posture, and de-identified delivery as an integrated stack. The structural difference shapes engagement velocity, data integrity (0.4% verified AI-respondent leak rate), and procurement clearance (most engagements clear in 30-60 days at top-20 pharma).
How For Pharma Marketing, Medical Affairs & Brand Teams use
Carevoices
Compliance Built In
BAA on every engagement, template available pre-signature. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Sunshine Act / Open Payments handling — NPI capture + CMS-format export. Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content.
Faster Insights
Fielding starts the same week the brief is locked. AI-moderated voice and video interviews with verified specialty physicians from a 10k+ healthcare panel. Recruitment takes 7-14 days for mainstream specialties (oncology, cardiology, GI, neurology, endocrinology); 14-28 days for rare subspecialties.
Always-On Listening
Monthly subscription with 50 interviews included means the next study fields the moment the prior one closes. Run buying-process, message validation, concept testing, advisory, tracker waves, and KOL deep-dives all within the same engagement — no per-project procurement cycle between studies.
Medical Affairs & KOL Research
KOL advisory boards, launch-readiness research, and Medical Affairs voice-of-physician programs run inside the same subscription as brand-team work. Stimuli pre-approval workflow, Sunshine Act-ready honoraria ledger, and BAA on every engagement clear MR legal, brand legal, and pharmacovigilance review on the first cycle.
How Carevoices compares to common pharma research alternatives
| Dimension | Carevoices | M3 / Sermo panel rentals | ZoomRx / RFP-driven pharma CRO | Listen Labs / generic AI tools |
|---|---|---|---|---|
| Engagement model | Monthly subscription with 50 interviews included; same-week fielding | Annual panel-access subscription + per-survey fees | RFP-driven custom engagement, 30-90 day procurement | Custom RFP-driven engagement design |
| AI-moderated voice/video qualitative | Native — primary delivery mechanism | Survey + community methodology | Hybrid AI + human moderation | Yes — but no healthcare compliance package |
| BAA on every engagement | Yes — template available pre-signature | Yes — standard for pharma engagements | Yes — standard for pharma engagements | No published BAA template; 60-120+ day legal retrofit |
| Stimuli pre-approval workflow for FDA-relevant content | Native — versioning + audit trail per stimulus | Survey-based; not designed for FDA-relevant stimuli testing | Available, layered onto custom engagement | Not built for FDA-relevant content |
| Iteration speed inside a launch window | Multiple study types within one subscription cycle | Per-survey fees on every round | New RFP cycle per round | Custom-scoped per round; no compliance reuse |
How pharma research teams use Carevoices
Brief us
You define the study question and audience. Our research agent translates the brief into a structured learning plan within 24 hours; recruitment feasibility confirmed before contract.
We recruit and moderate
AI-moderated voice or video interviews with verified clinicians. License + NPI verified at intake, behavioral fingerprinting across interviews, AI-on-AI fraud detection on every conversation.
We de-identify and deliver
Transcripts and recordings stripped of all 18 HIPAA Safe Harbor identifiers, then delivered to your team in standard formats your existing analysis stack already accepts.
You analyze
You analyze the de-identified data using your existing tools and team. We don't replace your analysis stack — we feed it the qualitative data your current vendors can't recruit for fast enough.
"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."
Stephane Nyombaire, CEO, Nivella Health
The Carevoices Difference for Pharma Research
Generic AI research tools and consumer-grade research platforms can be retrofit for pharma engagements — but the retrofit shows. Carevoices is built around healthcare compliance from day one. Here's how the architecture compares.
Carevoices Healthcare-Vertical Architecture
- BAA on every engagement, template available pre-signature
- License + NPI verified specialty physician panel (NPPES Registry cross-check at intake)
- HIPAA Safe Harbor de-identification built into delivery pipeline
- Sunshine Act / Open Payments handling — NPI capture + CMS-format export
- Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content
- 0.4% verified AI-respondent leak rate via 6-Layer Fraud Detection Stack
- PHI never trains a model — period
What Generic AI Research Tools Require
- BAA execution often unavailable or 60-120+ day legal retrofit
- Self-identified panel without license verification or NPI cross-check
- De-identification typically a post-fielding service charge or skipped entirely
- Sunshine Act handling not built; bolt-on per engagement
- No native stimuli pre-approval workflow for FDA-relevant content
- Legacy fraud detection that PNAS 2025 shows AI bots evade 99.8% of the time
- PHI in model training pipeline unless explicitly contracted otherwise
In progress: SOC 2 Type II audit (in evidence-collection phase). HITRUST CSF and ISO 27001 are 2026-2027 roadmap. Letter of audit attestation available on request to qualified prospects under NDA.
Run your next pharma study the week the brief is locked
Walk through your current research backlog. See how the monthly subscription fits. Get a sample compliant deliverable from a recent engagement.
Walkthrough of a sample compliant deliverable and how the monthly subscription fits your research backlog
Sample HIPAA-grade de-identified transcript and analysis from a recent specialty physician engagement
BAA template, identifier stripping methodology, US data residency commitment, Sunshine Act handling
Most engagements clear procurement within 30-60 days at top-20 pharma.
Common questions
Go deeper on For Pharma Marketing, Medical Affairs & Brand Teams
Pillar Guides
Deep-dive guides covering this topic from strategy to execution.
Compliance reference guides
Practical frameworks and platform-specific guides for teams ready to act.
Alternatives & Comparisons
Side-by-side comparisons with competing platforms and approaches.